Target intelligence / Profile preview

Selenocysteine lyase (SCL)

Target
SCL
Molecular classification
Enzyme, Lyase, carbon-sulfur lyase, EC 4.4.1.16
01

Overview

Selenocysteine lyase is a pyridoxal 5'-phosphate-dependent enzyme that specifically catalyzes the decomposition of L-selenocysteine to L-alanine and elemental selenium (selenide), contributing to the recycling of selenium from the degradation of selenoproteins[1][2][3][4][5][6][7]. It exhibits strict substrate specificity for L-selenocysteine and does not act on L-cysteine. Selenocysteine lyase is found primarily in the liver and kidney, usually as a homodimer in mammals, and plays a crucial cellular role in selenium metabolism and homeostasis by providing a source of selenide for new selenoprotein biosynthesis[7][3]. Its molecular structure includes a conserved catalytic cysteine residue essential for substrate specificity, and its activity is vital for maintaining optimal selenium levels in organisms[3][1]. There are no current drugs targeting selenocysteine lyase, nor is it a recognized direct therapeutic target or disease biomarker.

Other names
SCLSCLYL-selenocysteine selenide-lyase (L-alanine-forming)selenocysteine β-lyaseselenocysteine reductase
02

Biological functions

Selenium recycling from selenoprotein degradationSelenoamino acid metabolismSelenium homeostasis
03

Disease associations

Other (indirect implications in selenium deficiency, not directly established as a disease gene or direct disease target)

Beyond the preview

Go deeper on Selenocysteine lyase (SCL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Selenocysteine lyase (SCL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call